174 related articles for article (PubMed ID: 15557659)
21. [Immunity in hamsters after vaccination with monoxenic acid axenic cultures of E. histolytica].
Sepúlveda B; Tanimoto-Weki M; Guerrero A; Solís G
Arch Invest Med (Mex); 1973; ():Suppl 1:159-64. PubMed ID: 4363314
[No Abstract] [Full Text] [Related]
22. Identification of the Entamoeba histolytica galactose-inhibitable lectin epitopes recognized by human immunoglobulin A antibodies following cure of amebic liver abscess.
Abd-Alla MD; Jackson TF; Soong GC; Mazanec M; Ravdin JI
Infect Immun; 2004 Jul; 72(7):3974-80. PubMed ID: 15213142
[TBL] [Abstract][Full Text] [Related]
23. DNA vaccination with the serine rich Entamoeba histolytica protein (SREHP) prevents amebic liver abscess in rodent models of disease.
Zhang T; Stanley SL
Vaccine; 1999 Dec; 18(9-10):868-74. PubMed ID: 10580200
[TBL] [Abstract][Full Text] [Related]
24. A recombinant bivalent fusion protein rVE confers active and passive protection against Yersinia enterocolitica infection in mice.
Singh AK; Kingston JJ; Murali HS; Batra HV
Vaccine; 2014 Mar; 32(11):1233-9. PubMed ID: 24486353
[TBL] [Abstract][Full Text] [Related]
25. Vaccines for amoebiasis: barriers and opportunities.
Stanley SL
Parasitology; 2006; 133 Suppl():S81-6. PubMed ID: 17274850
[TBL] [Abstract][Full Text] [Related]
26. [Cellular hypersensitivity in amebiasis. I. Reactions in hamsters inoculated with E. histolytica].
Ortiz-Ortiz L; Garmilla C; Tanimoto-Weki M; Zamacona-Ravelo G
Arch Invest Med (Mex); 1973; ():Suppl 1:141-6. PubMed ID: 4363311
[No Abstract] [Full Text] [Related]
27. Protection against amebic liver abscess formation in the severe combined immunodeficient mouse by human anti-amebic antibodies.
Seydel KB; Braun KL; Zhang T; Jackson TF; Stanley SL
Am J Trop Med Hyg; 1996 Sep; 55(3):330-2. PubMed ID: 8842124
[TBL] [Abstract][Full Text] [Related]
28. Immunogenicity of the recombinant serine rich Entamoeba histolytica protein (SREHP) amebiasis vaccine in the African green monkey.
Stanley SL; Blanchard JL; Johnson N; Foster L; Kunz-Jenkins C; Zhang T; Tian K; Cogswell FB
Vaccine; 1995 Jul; 13(10):947-51. PubMed ID: 7483769
[TBL] [Abstract][Full Text] [Related]
29. Antigen induced eosinophilia protects gerbils (Meriones unguiculatus) against experimental amebic abscess of the liver.
Velázquez JR; Llaguno P; Fernández-Diéz J; Pérez-Rodríguez M; Arellano J; López-Osuna M; Kretschmer RR
Arch Med Res; 1995; 26 Spec No():S93-8. PubMed ID: 8845666
[TBL] [Abstract][Full Text] [Related]
30. Entamoeba histolytica: cDNAs cloned as 30kDa collagen-binding proteins (CBP) belong to an antioxidant molecule family. Protection of hamsters from amoebic liver abscess by immunization with recombinant CBP.
Jiménez-Delgadillo B; Chaudhuri PP; Baylón-Pacheco L; López-Monteon A; Talamás-Rohana P; Rosales-Encina JL
Exp Parasitol; 2004; 108(1-2):7-17. PubMed ID: 15491543
[TBL] [Abstract][Full Text] [Related]
31. Vaccine prospects for amebiasis.
Chaudhry OA; Petri WA
Expert Rev Vaccines; 2005 Oct; 4(5):657-68. PubMed ID: 16221067
[TBL] [Abstract][Full Text] [Related]
32. [Probable amebic brain abscess in a homosexual man with an Entamoeba histolytica liver abscess].
Yamasaki M; Taniguchi A; Nagai M; Sasaki R; Naito Y; Kuzuhara S
Rinsho Shinkeigaku; 2007 Oct; 47(10):672-5. PubMed ID: 18095503
[TBL] [Abstract][Full Text] [Related]
33. [Immunogenicity of a delipidated antigen of Entamoeba histolytica].
Oliva A; Correa I; Ortiz-Ortiz L
Arch Invest Med (Mex); 1986; 17 Suppl 1():229-32. PubMed ID: 2884961
[No Abstract] [Full Text] [Related]
34. Identification of A 35 kDa glycoprotein from the outer membrane of Entamoeba histolytica by sera from patients with amebic liver abscess and with mouse monoclonal antibody.
Agundis-Mata C; Blanco F; Chávez K; Cervera H; Kumate J; Isibasi A
Arch Med Res; 1997; 28 Spec No():264-6. PubMed ID: 9033095
[No Abstract] [Full Text] [Related]
35. Oral immunization with a recombinant cysteine-rich section of the Entamoeba histolytica galactose-inhibitable lectin elicits an intestinal secretory immunoglobulin A response that has in vitro adherence inhibition activity.
Beving DE; Soong CJ; Ravdin JI
Infect Immun; 1996 Apr; 64(4):1473-6. PubMed ID: 8606122
[TBL] [Abstract][Full Text] [Related]
36. Yersinia enterocolitica: subversion of adaptive immunity and implications for vaccine development.
Autenrieth SE; Autenrieth IB
Int J Med Microbiol; 2008 Jan; 298(1-2):69-77. PubMed ID: 17702651
[TBL] [Abstract][Full Text] [Related]
37. Yersinia enterocolitica differentially modulates RhoG activity in host cells.
Roppenser B; Röder A; Hentschke M; Ruckdeschel K; Aepfelbacher M
J Cell Sci; 2009 Mar; 122(Pt 5):696-705. PubMed ID: 19208761
[TBL] [Abstract][Full Text] [Related]
38. Entamoeba histolytica: antibody responses and lymphoreticular changes in gerbils (Meriones unguiculatus) in response to experimental liver abscess and amebic extract infection.
Chadee K; Meerovitch E
Z Parasitenkd; 1984; 70(6):781-95. PubMed ID: 6098090
[TBL] [Abstract][Full Text] [Related]
39. Oral immunization against cholera toxin with a live Yersinia enterocolitica carrier in mice.
Van Damme M; Sory MP; Biot T; Vaerman JP; Cornelis GR
Gastroenterology; 1992 Aug; 103(2):520-31. PubMed ID: 1634070
[TBL] [Abstract][Full Text] [Related]
40. In vitro and in vivo expression studies of yopE from Yersinia enterocolitica using the gfp reporter gene.
Jacobi CA; Roggenkamp A; Rakin A; Zumbihl R; Leitritz L; Heesemann J
Mol Microbiol; 1998 Nov; 30(4):865-82. PubMed ID: 10094634
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
